| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/11/2004 | US6734344 Coniothyrium minitans β-(1,3) exoglucanase gene cbeg 1 |
| 05/11/2004 | US6734343 Polynucleotide comprising nucleotide sequence encoding polypeptide having flavanone-7-o-glucoside-2''-o-rhamnosyl-transferase catalytic activity |
| 05/11/2004 | US6734342 Theobromine synthase polypeptide of coffee plant and the gene encoding said polypeptide |
| 05/11/2004 | US6734341 Synthases/polypeptides for altering concentration or morphology of glucans/polysaccharide/amylose in plants; gene expression inhibition; genetic mapping |
| 05/11/2004 | US6734340 Monocotyledon plant cells and plants which synthesise modified starch |
| 05/11/2004 | US6734339 Transformed plant cells and plants regenerated from these cells, which exhibit an increase or reduced activity of starch synthases; genetic engineering |
| 05/11/2004 | US6734336 Useful in identifying compounds for treating alzheimer's disease |
| 05/11/2004 | US6734296 Probe/mobility modifier complexes for multiplex nucleic acid detection |
| 05/11/2004 | US6734295 Modified CRE recombinase gene for mammals |
| 05/11/2004 | US6734293 Novel extracts, proteins, and complexes that improve the polymerization activity of nucleic acid polymerases |
| 05/11/2004 | US6734289 Gastrokines and derived peptides including inhibitors |
| 05/11/2004 | US6734288 Antibodies against a secreted polypeptide that stimulates release of proteoglycans from cartilage |
| 05/11/2004 | US6734286 Interleukin-5 specific recombinant antibodies |
| 05/11/2004 | US6734284 Exhibits high affinity for the gfr alpha 3- ret receptor complex and unique subregions in its amino acid sequence |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/11/2004 | US6734174 Modulators of the function of receptors of the TNF/NGF receptor |
| 05/11/2004 | US6734172 Surface receptor antigen vaccines |
| 05/11/2004 | US6734168 Endothelial monocyte activating polypeptide II: a mediator which activates host response |
| 05/11/2004 | US6734161 Peptide nucleic acids having antibacterial activity |
| 05/11/2004 | US6734160 Nucleotide sequences coding polypeptide for use in the treatment of diabetes |
| 05/11/2004 | US6734019 Used in plant breeding |
| 05/11/2004 | US6734017 Gene expression inhibition; antiproliferative, anticancer and antiarthritic agents; angiogenesis inhibitors |
| 05/11/2004 | US6734013 Genetic engineering |
| 05/11/2004 | US6734010 Human kinases and polynucleotides encoding the same |
| 05/11/2004 | US6734009 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of immunological, brain and psychological disorders |
| 05/11/2004 | US6734007 Human proteases and polynucleotides encoding the same |
| 05/11/2004 | US6734006 Used to regulate extracellular matrix degradation, treats chronic obstructive pulmonary disease (copd) metastasis of malignant cells, tumor angiogenesis, inflammation, atherosclerosis and neurodegenerative diseases |
| 05/11/2004 | US6734004 Modified phytases |
| 05/11/2004 | US6734003 Phosphodiesterase 10 |
| 05/11/2004 | US6734002 Nucleotide sequences coding for the chrS protein |
| 05/11/2004 | US6733998 For proteins and enzymes used in biosynthetic pathway and construction of aryltetrasaccharide and aglycone |
| 05/11/2004 | US6733997 Isolated nucleic acids encoding a secretory signal for expression and secretion of heterologous recombinant proteins |
| 05/11/2004 | US6733996 Methods for regulating gene expression using light |
| 05/11/2004 | US6733995 Cathepsin L, its prepro form and the corresponding propeptide from ciliates |
| 05/11/2004 | US6733994 Highly expressible genes |
| 05/11/2004 | US6733993 Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-gag, pol, nef and modifications |
| 05/11/2004 | US6733992 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
| 05/11/2004 | US6733991 For indentifying receptor-independent activators of pheromone response pathway; devised in yeast saccharomyces cerevisiae; activator of g-protein signaling (ags) |
| 05/11/2004 | US6733990 Useful for the treatment of immune, hematologic, fibrotic, hepatic, and respiratory disorders such as asthma using g-protein coupled receptors (gpcr) |
| 05/11/2004 | US6733989 Structural phosphoprotein (pp28) of human cytomegalovirus (HCMV), the preparation and use thereof |
| 05/11/2004 | US6733981 Antibodies to interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| 05/11/2004 | US6733980 Diagnostic method for detection of molecular forms of eosinophilic cationic protein (ISO-ECPS) |
| 05/11/2004 | US6733978 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/11/2004 | US6733975 DNA chip and its preparation |
| 05/11/2004 | US6733972 Detection of mycosphaerella using the polymerase chain reaction |
| 05/11/2004 | US6733970 Screening system for zinc finger polypeptides for a desired binding ability |
| 05/11/2004 | US6733968 Luminescent intensities of the inter-pin error correction control spots are measured using a microarray reader, thereby obtaining spotting amount of error information |
| 05/11/2004 | US6733777 Cationic reagents of transfection |
| 05/11/2004 | US6733758 Fibrinogen binding protein originating from coagulase-negative staphylococcus |
| 05/11/2004 | US6733757 Adeno-associated virus capsid polypeptide for use as gene transfer tool in cell tranduction |
| 05/11/2004 | US6733755 Ligand for vascular endothelial growth factor receptor |
| 05/11/2004 | US6733648 Electrophoresis chip |
| 05/11/2004 | CA2222581C Oligonucleotide tags for sorting and identification |
| 05/11/2004 | CA2184411C Process for preparing polymorphs b and c of 1-[2,4-dichloro-.beta.-[(7-chlorobenzo[b]thien-3-yl)methoxy]phenethyl]imidazole mononitrate |
| 05/11/2004 | CA2074188C Vector with multiple tat activation response elements affecting gene expression |
| 05/11/2004 | CA2045950C Recombinant vaccine for prevention and/or treatment of pleuropneumonia infections |
| 05/11/2004 | CA2004056C Method and reagent combination for determining nucleotide sequences |
| 05/08/2004 | CA2512484A1 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 05/06/2004 | WO2004038029A1 Method of transferring gene into t cells |
| 05/06/2004 | WO2004038027A1 Bioremediation |
| 05/06/2004 | WO2004038026A2 Calcineurin-like human phosphoesterase |
| 05/06/2004 | WO2004038025A2 Genes and proteins for the biosynthesis of the glycopeptide antibiotic a40926 |
| 05/06/2004 | WO2004038024A1 Recombinant mva strains as potential vaccines against p. falciparum malaria |
| 05/06/2004 | WO2004038023A1 Method for producing a transgenic plant with the aid of agrobacterium tumefaciens |
| 05/06/2004 | WO2004038022A1 Method of examining swine genetic resistance to rna virus-origin disease |
| 05/06/2004 | WO2004038021A1 Gpr54 knock-out mammals and screening methods using them |
| 05/06/2004 | WO2004038020A1 Target genes for the diagnosis and treatment of cancer |
| 05/06/2004 | WO2004038019A2 Dnazyme cleaving mutant polynucleotides |
| 05/06/2004 | WO2004038018A1 Gene expressed specifically in dopamine-producing neuron precursor cells after termination of division |
| 05/06/2004 | WO2004038017A1 Isomaltose synthase-knockout microorganism belonging eumycota |
| 05/06/2004 | WO2004038016A1 Method of degrading plastic and process for producing useful substance using the same |
| 05/06/2004 | WO2004038014A1 Dna storing medium and method of storing dna |
| 05/06/2004 | WO2004038007A2 Dna polymerases with reduced base analog detection activity |
| 05/06/2004 | WO2004038003A2 Human polypeptides encoded by polynucleotides and methods of their use |
| 05/06/2004 | WO2004037998A2 Natural promoters for gene expression in c1 metabolizing bacteria |
| 05/06/2004 | WO2004037993A2 Methods of producing a library and methods of selecting polynucleotides of interest |
| 05/06/2004 | WO2004037988A2 Methods for synthesizing complementary dna |
| 05/06/2004 | WO2004037987A2 Secreted proteins |
| 05/06/2004 | WO2004037983A2 Caged ligands and uses thereof |
| 05/06/2004 | WO2004037982A2 High expression locus vector based on ferritin heavy chain gene locus |
| 05/06/2004 | WO2004037981A2 Triplex-forming oligonucleotides containing modified purines and their applications |
| 05/06/2004 | WO2004037977A2 Use of chimeric nucleases to stimulate gene targeting |
| 05/06/2004 | WO2004037976A2 NONSENSE-MEDIATED mRNA DECAY |
| 05/06/2004 | WO2004037975A2 Composition and method for imaging cells |
| 05/06/2004 | WO2004037973A2 Zymomonas pentose-sugar fermentating strains and uses thereof |
| 05/06/2004 | WO2004037972A2 Endogenous retrovirus up-regulated in prostate cancer |
| 05/06/2004 | WO2004037861A2 Neutralizing antibodies against gdf-8 and uses therefor |
| 05/06/2004 | WO2004037860A1 Epididymis-specific gene as potential contraceptive target |
| 05/06/2004 | WO2004037858A2 Nipa, a nuclear interacting partner of anaplastic lymphoma kinase, polypeptides and use thereof |
| 05/06/2004 | WO2004037856A2 Plasmodium falciparum virulence factor var o |
| 05/06/2004 | WO2004037848A2 Process for determining target function and identifying drug leads |
| 05/06/2004 | WO2004037846A1 Immunisation against components of the human immunodeficiency virus (hiv) |
| 05/06/2004 | WO2004037294A2 New settings for recombinant adenoviral-based vaccines |
| 05/06/2004 | WO2004037278A2 Delocalization molecules and use thereof |
| 05/06/2004 | WO2004037202A2 Gb virus c and methods of treating viral infections |
| 05/06/2004 | WO2004037194A2 Novel compositions with chitinase activity |
| 05/06/2004 | WO2004024929A3 Proximity-aided synthesis of templated molecules |
| 05/06/2004 | WO2004024870A3 Construction of bacillus licheniformis t1 strain and fermentation production of crude enzyme extract therefrom |
| 05/06/2004 | WO2004023137A3 Method for screening for mutant virus movement proteins (mp) |
| 05/06/2004 | WO2004022755A3 Polypeptides involved in the regulation of flowering in forage grasses |